• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Apollomics Inc. - Class A Ordinary Shares (NQ: APLM )

    0.3110 -0.0059 (-1.86%)
    Streaming Delayed Price Updated: 3:59 PM EDT, May 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 96,987
    Open 0.3360
    Bid (Size) 0.3050 (1)
    Ask (Size) 0.3400 (3)
    Prev. Close 0.3169
    Today's Range 0.3100 - 0.3360
    52wk Range 0.3100 - 6.450
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Apollomics Announces Private Placement Financing and Addition to Board of Directors
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
    From Apollomics Inc.
    Via GlobeNewswire

    Performance

    YTD
    -66.17%
    -66.17%
    1 Month
    -34.53%
    -34.53%
    3 Month
    -52.23%
    -52.23%
    6 Month
    -61.13%
    -61.13%
    1 Year
    -92.32%
    -92.32%

    More News

    Read More
    Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Announces Poster Presentations of Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    From Apollomics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
    From Apollomics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Apollomics to Announce Full Year 2023 Financial Results and Host Conference Call on March 28, 2024
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
    From Apollomics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Apollomics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    From Apollomics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
    From Apollomics Inc.
    Via GlobeNewswire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Week In Review: 2024 Kicks Off With Three Deals Worth A Total Of $4 Billion
    Via Talk Markets
    Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics to Present at the 2024 Biotech Showcase
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation
    From Apollomics Inc.
    Via GlobeNewswire
    Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Via InvestorPlace
    Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
    From Apollomics Inc.
    Via GlobeNewswire
    Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.